INSTITUT NATIONAL DES SCIENCES APPLIQUEES DE LYON;UNIVERSITE CLAUDE BERNARD LYON 1;INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM)
发明人:
MICHEL LAGARDE,EVELYNE VERICEL,MADELEINE PICQ,NATHALIE BERNOUD-HUBAC,MICHEL GUICHARDANT
申请号:
FR1158149
公开号:
FR2979825B1
申请日:
2011.09.13
申请国别(地区):
FR
年份:
2013
代理人:
摘要:
The present invention relates to a pharmaceutical composition or a medicament for use in preventing or treating a PAF-related disease, comprising a phosphatidylcholine of formula (I), and also to the use of such a compound as a medicament or as a modulator of PAF activity.